Nelarabine Injection
Product Images NDC 70710-1839

This is a description of a 50 mL single-dose vial of Nelarabine Injection for intravenous infusion. Each mL contains 5 mg of nelarabine and the vial also contains sodium, hydroxide NF and/or chloride USP for tonicity adjustment and hydrochloric acid NF for pH adjustment. This medication should not be diluted and does not contain preservatives. The vial stoppers are not made with natural rubber latex. It is manufactured by Cadila Healthcars Ltd in India and distributed by Zytus Pharmaceuticals (USA) Inc. The usual dose is found in the package insert. Storage should be at 25°C (77°F) with excursions permitted to 15°C - 30°C (59°F - 86°F) [see USP Controlled Room Temperature]. The lot number is X00000KK.*

This appears to be a description of a pharmaceutical product called Nelarabine. It is an injection that contains 5mg of the active ingredient per mL, as well as 4.5mg of sodium chloride. The injection should not be diluted and does not contain preservatives. The packaging should not be used if the plastic seal is missing or damaged. The manufacturer is Cadila Healthcare Ltd in India, and the product is distributed in the US by Zyius Pharmaseuticas under the trademark novaplus.*

This is a description of a medication called Nelarabine Injection, distributed by Novaplus*. It is an intravenous infusion medication and comes in 250mg/50mL (5mg/mL) dosage. The package warns not to use the solution if cloudy or contains precipitate, and to check for plastic over-seal before use. The unused portion should be discarded. The text includes a digitally signed approval from Courtney Corbin, Quality Assurance Manager, Vizient Legal & Compliance.*